Geographic variation within the United States in the incidence of hepatocellular carcinoma

Journal of Clinical Epidemiology

Volumn 56, Issue 5, 2003, Pages 487-493

  Davila, Jessica A ^a,b   Petersena, Nancy J ^a,b   Nelson, Harlan A ^a   El Serag, Hashem B ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiology; Geographic variation; Hepatocellular carcinoma; SEER

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANALYTICAL PARAMETERS; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ETHNOLOGY; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); GEOGRAPHY; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INDIAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; POISSON DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICAL MODEL; UNITED STATES;

EID: 0037905592     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00605-4     Document Type: Article

References (26)

1. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 340:1999;745-750.
2. Di Bisceglie A.M. Malignant tumors of the liver. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's diseases of the liver. 8th ed:1999;1281-1304 Lippincott-Raven Publishers, Philadelphia.
3. El-Serag H.B., Mason A.C. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 160:2000;3227-3230.
4. El Serag H.B., Richardson P.A., Everhart J.E. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 96:2001;2462-2467.
5. McGlynn K.A., Tsao L., Hsing A.W., Devesa S.S., Fraumeni J.F. Jr. International trends and patterns of primary liver cancer. Int J Cancer. 94:2001;290-296.
6. Surveillance, Epidemiology, and End Results (SEER) program public-use CD-ROM (1973-1998). National Cancer Institute: Bethesda, MD, April 2001 (software).
7. Behavioral Health Risk Factor Surveillance System. December 21, 2000. Centers for Disease Control. 〈 http://www.cdc.gov/nccdphp/brfss/
8. Percy C., Van Holten V., Muir C. International classification of diseases for oncology. 2nd ed:1990;World Health Organization, Geneva.
9. SAS Institute Inc. SAS/STAT software: changes and enhancements. release 8.0. 1994;SAS Institute Inc, Cary, NC. p. 85.
10. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS system for mixed models. 1996;SAS Institute Inc, Cary, NC. p. 1-29.
11. Burton P., Gurrin L., Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modeling. Stat Med. 17:1998;1261-1291.
12. Bryk A.S., Raudenbush S.W. Hierarchical linear models. 1992;Sage Publications, Newbury Park, CA. p. 9-31.
13. In Bryk A.S., Raudenbush S.W. Hierarchical linear models. 1992;Sage Publications, Newbury Park, CA. p. 32-59.
14. In Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS system for mixed models. 1996;SAS Institute Inc, Cary, NC. p. 1-29.
15. Campbell M., Grimshaw J., Steen N. Sample size calculations for cluster randomized trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). J Health Serv Res Policy. 5:2000;12-16.
16. El Serag H.B. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 5:2001;87-107.
17. McQuillan G.M., Alter M.J., Everhart J.E. Viral hepatitis. Everhart J.E. Digestive diseases in the United States: epidemiology and impact. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1994;U.S. Government Printing Office, Washington DC. NIH publication No. 94-1447.
18. McQuillan G.M., Townsend T.R., Fields H.A., Carroll M., Leahy M., Polk B.F. Seroepidemiology of hepatitis B virus infection in the United States, 1976-1980. Am J Med. 87:(suppl 3A):1989;5S-10S.
19. Suzuki M., Suzuki H., Mizuno H., Tominaga T., Kono M., Kato Y., Sato A., Okabe K. Studies on the incidence of hepatocellular carcinoma in heavy drinkers with liver cirrhosis. Alcohol Suppl. 1B:1993;109-114.
20. Everhart J.E., Herion D. Alcohol and hepatitis C. Liang J., Hoofnagle J.H. Hepatitis C. 2000;363-387 Academic Press, San Diego.
21. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology. 121:2001;710-723.
22. Silverman J.F., O'Brien K.F., Long S., Leggett N., Khazanie P.G., Pories W.J., et al. Liver pathology in morbidly obese with and without diabetes. Am J Gastroenterol. 85:1990;1349-1355.
23. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 29:1999;664-669.
24. Yu M.C., Tong M.J., Govindarajan S., Henderson B.E. Nonviral risk factors for hepatocellular carcinoma in a low risk population, the non-Asians of Los Angeles County. Calif Natl Cancer Inst. 83:1991;1820-1826.
25. La Vecchia C., Negri E., Decarli A., Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer. 73:1997;204-207.
26. Adami H.O., Chow W.H., Nyren O., Berne C., Linet M.S., Ekbom A., Wolk A., McLaughlin J.K., Fraumeni J.F. Jr. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 88:1996;1472-1477.